References
- ThangarajRGrimerRJCarterSRStirlingAJSpilsburyJSpoonerDGiant cell tumour of the sacrum: a suggested algorithm for treatmentEur Spine J20101971189119420076978
- CampanacciMBaldiniNBorianiSSudaneseAGiant-cell tumor of boneJ Bone Joint Surg Am19876911061143805057
- KamalAFSimbolonELPrabowoYHutagalungEUWide resection versus curettage with adjuvant therapy for giant cell tumour of boneJ Orthop Surg2016242228231
- GastonCLBhumbraRWatanukiMDoes the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?J Bone Joint Surg Br201193-B1216651669
- BalkeMSchremperLGebertCGiant cell tumor of bone: treatment and outcome of 214 casesJ Cancer Res Clin Oncol2008134996997818322700
- BeneveniaJRiveroSMMooreJSupplemental bone grafting in giant cell tumor of the extremity reduces nononcologic complicationsClin Orthop Relat Res2017475377678326932739
- ChanCMAdlerZReithJDGibbsCPRisk factors for pulmonary metastases from giant cell tumor of boneJ Bone Joint Surg Am201597542042825740033
- van der HeijdenLDijkstraPDvan de SandeMAThe clinical approach toward giant cell tumor of boneOncologist201419555056124718514
- NithyananthMPriscillaAJBoopalanPVTitusVTLeeVNTime required for effective action of phenol against giant cell tumour cellsJ Orthop Surg2014221104107
- van der HeijdenLvan der GeestICSchreuderHWvan de SandeMADijkstraPDLiquid nitrogen or phenolization for giant cell tumor of bone? A comparative cohort study of various standard treatments at two tertiary referral centersJ Bone Joint Surg Am2014965e3524599207
- ChaudharyPKhadimHGajraADamronTShahCBisphosphonate therapy is effective in the treatment of sacral giant cell tumorOnkologie2011341270270422156450
- BorkowskaAGoryńTPieńkowskiADenosumab treatment of inoperable or locally advanced giant cell tumor of boneOncol Lett20161264312431828101196
- BalkeMCampanacciLGebertCBisphosphonate treatment of aggressive primary, recurrent and metastatic giant cell tumour of boneBMC Cancer201010146220799989
- LauCPHuangLWongKCKumtaSMComparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of boneConnect Tissue Res201354643944924060052
- MüllerDABeltramiGScocciantiGCampanacciDAFranchiACapannaRRisks and benefits of combining denosumab and surgery in giant cell tumor of bone – a case seriesWorld J Surg Oncol201614128127809843
- ErraniCTsukamotoSLeoneGDenosumab may increase the risk of local recurrence in patients with giant-cell tumor of bone treated with curettageJ Bone Joint Surg Am2018100649650429557866
- MakIWEvaniewNPopovicSTozerRGhertMA translational study of the neoplastic cells of giant cell tumor of bone following neoadjuvant denosumabJ Bone Joint Surg Am20149615e12725100780
- ShibuyaITakamiMMiyamotoAIn vitro study of the effects of denosumab on giant cell tumor of bone: comparison with zoledronic acidPathol Oncol Res Epub20171120
- YokoyamaTMizuguchiMOstermannAProtonation state and hydration of bisphosphonate bound to farnesyl pyrophosphate synthaseJ Med Chem201558187549755626314394
- ChengYYHuangLKumtaSMLeeKMLaiFMTamJSCytochemical and ultrastructural changes in the osteoclast-like giant cells of giant cell tumor of bone following bisphosphonate administrationUltrastruct Pathol200327638539114660277
- ChangSSSuratwalaSJJungKMBisphosphonates may reduce recurrence in giant cell tumor by inducing apoptosisClin Orthop Relat Res2004426103109
- ChenKHWuPKChenCFChenWMZoledronic acid-loaded bone cement as a local adjuvant therapy for giant cell tumor of the sacrum after intralesional curettageEur Spine J201524102182218825940568
- TseLFWongKCKumtaSMHuangLChowTCGriffithJFBisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control studyBone2008421687317962092
- ZhengXYinQKumtaSMHuangHZhangYZhangTClinical study of bisphosphonates reducing local recurrence in extremity giant cell tumor of boneChinese Clin Oncol20091411001104
- FanJAnalysis of Zoledronic Acid to Assist Clinical Effect Surgical Treatment for Giant Cell Tumor of Bone [master thesis]Changsha, Hunan, ChinaCentral South University2013
- XuWXuLLiLPrognostic factors of giant cell tumor in mobile spineChin J Orthop201434487493
- DingLHanXHuangTZhangHAdjuvant administration of bisphosphonates decreases local recurrence rate of extremity giant cell tumor of boneChin J Heal Care Med2016186769
- XuWWangYWangJLong-term administration of bisphosphonate to reduce local recurrence of sacral giant cell tumor after nerve-sparing surgeryJ Neurosurg Spine201782204716721
- KunduZSSenRDhimanASharmaPSiwachRRanaPEffect of intravenous zoledronic acid on histopathology and recurrence after extended curettage in giant cell tumors of bone: a comparative prospective studyIndian J Orthop2018521455029416169
- LiberatiAAltmanDGTetzlaffJThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaborationBMJ2009339jul21 1b270019622552
- ShiMChenLWangYWangWYanSEffect of bisphosphonates on local recurrence of giant cell tumor. PROSPERO International prospective register of systematic reviews web Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018087636Accessed September 8, 2018
- BeckerLCochrane Handbook for Systematic Reviews of Interventions Version 5.1.4Chichester, EnglandWiley-Blackwell2011
- HigginsJPTThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
- WellsGSheaBO’ConnellDThe Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-AnalysesOttawa, Ontario, CanadaOttawa Hospital Research Institute2013
- StangACritical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEur J Epidemiol201025960360520652370
- SchünemannHJOxmanADBrozekJGrading quality of evidence and strength of recommendations for diagnostic tests and strategiesBMJ200833676531106111018483053
- McgoughRLRutledgeJLewisVOLinPPYaskoAWImpact severity of local recurrence in giant cell tumor of boneClin Orthop Relat Res200543811612216131879
- Arbeitsgemeinschaft KnochentumorenBeckerWTDohleJLocal recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapyJ Bone Joint Surg Am20089051060106718451399
- ErraniCRuggieriPAsenzioMAGiant cell tumor of the extremity: a review of 349 cases from a single institutionCancer Treat Rev20103611719879054
- KlenkeFMWengerDEInwardsCYRosePSSimFHGiant cell tumor of bone: risk factors for recurrenceClin Orthop Relat Res2011469259159920706812
- MozaffarianKModjallalMVosoughiARTreatment of giant cell tumor of distal radius with limited soft tissue invasion: curettage and cementing versus wide excisionJ Orthop Sci201823117417929110910
- PazionisTJAlradwanHDeheshiBMTurcotteRFarrokhyarFGhertMA systematic review and meta-analysis of en-bloc vs intralesional resection for giant cell tumor of bone of the distal radiusOpen Orthop J20137110310823730371
- GortzakYKandelRDeheshiBThe efficacy of chemical adjuvants on giant-cell tumour of bone. An in vitro studyJ Bone Joint Surg Br201092101475147921089702
- BoissierSFerrerasMPeyruchaudOBisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastasesCancer Res200060112949295410850442
- XuLJinJHuASoft tissue recurrence of giant cell tumor of the bone: prevalence and radiographic featuresJ Bone Oncol20179101429018768
- KarpikMGiant cell tumor (tumor gigantocellularis, osteoclastoma)--epidemiology, diagnosis, treatmentOrtop Traumatol Rehabil201012320721520675862
- MiglioratiCAWooSBHewsonIA systematic review of bisphosphonate osteonecrosis (BON) in cancerSupport Care Cancer20101881099110620411279
- SellmeyerDEAtypical fractures as a potential complication of long-term bisphosphonate therapyJAMA2010304131480148420924014
- RutkowskiPGastonLBorkowskaADenosumab treatment of inoperable or locally advanced giant cell tumor of bone--Multicenter analysis outside clinical trialEur J Surg Oncol20184491384139029650420
- ChawlaSHenshawRSeegerLSafety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 studyLancet Oncol201314990190823867211